Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Teupser

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Pharmacology & Physiology|December 23, 2006
Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytesMathias Bruegel, Daniel Teupser, Ivonne Haffner, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2013
Quantification of linezolid in serum by LC-MS/MS using semi-automated sample preparation and isotope dilution internal standardizationJohannes Zander, Barbara Maier, Michael Zoller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2008
Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient miceLesca M Holdt, Joachim Thiery, Jan L Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2005
Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- miceDaniel Teupser, Marietta Tan, Adam D Persky, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 14, 2010
Identification of mutations in the lipoprotein lipase (LPL) and apolipoprotein C-II (APOC2) genes using denaturing high performance liquid chromatography (DHPLC)Kathrin B Schuster, Wolfgang Wilfert, David Evans, et al.
Atherosclerosis|November 6, 2007
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemiaMarc A Mueller, Frank Beutner, Daniel Teupser, et al.
Obesity Facts|September 17, 2011
Features of the metabolic syndrome in the Berlin Fat Mouse as a model for human obesityClaudia Hantschel, Asja Wagener, Christina Neuschl, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 5, 2023
Therapeutic drug monitoring in breast cancer therapy - LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serumKatharina Habler, Anne-Sophie Kalla, Michael Rychlik, et al.
Journal of Visualized Experiments : Jove|September 18, 2018
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical IllnessesCarina Schuster, Sebastian Sterz, Daniel Teupser, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2005
Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistanceDaniel Teupser, Ralph Burkhardt, Wolfgang Wilfert, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Pharmacology & Physiology|December 23, 2006
Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytesMathias Bruegel, Daniel Teupser, Ivonne Haffner, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2013
Quantification of linezolid in serum by LC-MS/MS using semi-automated sample preparation and isotope dilution internal standardizationJohannes Zander, Barbara Maier, Michael Zoller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2008
Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient miceLesca M Holdt, Joachim Thiery, Jan L Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2005
Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- miceDaniel Teupser, Marietta Tan, Adam D Persky, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 14, 2010
Identification of mutations in the lipoprotein lipase (LPL) and apolipoprotein C-II (APOC2) genes using denaturing high performance liquid chromatography (DHPLC)Kathrin B Schuster, Wolfgang Wilfert, David Evans, et al.
Atherosclerosis|November 6, 2007
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemiaMarc A Mueller, Frank Beutner, Daniel Teupser, et al.
Obesity Facts|September 17, 2011
Features of the metabolic syndrome in the Berlin Fat Mouse as a model for human obesityClaudia Hantschel, Asja Wagener, Christina Neuschl, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 5, 2023
Therapeutic drug monitoring in breast cancer therapy - LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serumKatharina Habler, Anne-Sophie Kalla, Michael Rychlik, et al.
Journal of Visualized Experiments : Jove|September 18, 2018
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical IllnessesCarina Schuster, Sebastian Sterz, Daniel Teupser, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2005
Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistanceDaniel Teupser, Ralph Burkhardt, Wolfgang Wilfert, et al.
Pageof 19